Unveiling some FDA-approved drugs as inhibitors of the store-operated Ca2+ entry pathway
Crossref DOI link: https://doi.org/10.1038/s41598-017-13343-x
Published Online: 2017-10-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rahman, Saifur
Rahman, Taufiq
Text and Data Mining valid from 2017-10-16
Version of Record valid from 2017-10-16
Article History
Received: 27 June 2017
Accepted: 21 September 2017
First Online: 16 October 2017
Competing Interests
: The authors declare that they have no competing interests.